Fenofibrate Capsule
Product Images NDC 60505-3120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 60505-3120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl130mg30s (Lbl130mg30s)

Fenofibrate Capsules, USP 130 mg label showing a package of 30 capsules. The label includes storage instructions, dispensing information, and manufacturer details from Apotex Corp. The label also shows an NDC code 60505-3121-3 and a barcode, with the product indicated for oral use and prescription only.*

FDA Label Image

Lbl43mg30s (Lbl43mg30s)

Label for Fenofibrate Capsules USP 43 mg by Apotex Corp. The label indicates a package containing 30 capsules. It shows storage instructions (20°C to 25°C with permitted excursions), advises dispensing in a tight container, and includes manufacturing details for Apotex Inc. in Toronto, Canada, and Apotex Corp. in Florida. The label also displays the NDC 60505-3120-3 and a barcode.*

FDA Label Image

Chemical-structure (Structure)

Chemical structure diagram of fenofibrate, illustrating the molecular arrangement of the active ingredient fenofibrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.